11.93
Precedente Chiudi:
$11.70
Aprire:
$11.93
Volume 24 ore:
408.18K
Relative Volume:
0.87
Capitalizzazione di mercato:
$485.37M
Reddito:
$324.01M
Utile/perdita netta:
$-192.37M
Rapporto P/E:
-2.4958
EPS:
-4.78
Flusso di cassa netto:
$-23.46M
1 W Prestazione:
+0.97%
1M Prestazione:
+11.32%
6M Prestazione:
+28.44%
1 anno Prestazione:
+64.31%
Angiodynamic Inc Stock (ANGO) Company Profile
Nome
Angiodynamic Inc
Settore
Industria
Telefono
(518) 798-1215
Indirizzo
14 PLAZA DRIVE, LATHAM
Confronta ANGO con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
ANGO
Angiodynamic Inc
|
11.95 | 482.04M | 324.01M | -192.37M | -23.46M | -4.78 |
![]()
ISRG
Intuitive Surgical Inc
|
527.47 | 165.88B | 9.15B | 2.63B | 1.99B | 7.1661 |
![]()
BDX
Becton Dickinson Co
|
188.97 | 54.18B | 21.39B | 1.61B | 2.55B | 5.5609 |
![]()
RMD
Resmed Inc
|
268.36 | 39.14B | 5.15B | 1.40B | 1.65B | 9.5082 |
![]()
ALC
Alcon Inc
|
76.30 | 37.46B | 10.03B | 1.07B | 1.39B | 2.1549 |
![]()
WST
West Pharmaceutical Services Inc
|
279.47 | 20.09B | 2.96B | 487.70M | 344.00M | 6.6758 |
Angiodynamic Inc Stock (ANGO) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-07-16 | Iniziato | Lake Street | Buy |
2024-04-05 | Aggiornamento | Oppenheimer | Perform → Outperform |
2023-09-25 | Iniziato | H.C. Wainwright | Buy |
2023-04-17 | Downgrade | Raymond James | Strong Buy → Outperform |
2021-10-15 | Aggiornamento | Canaccord Genuity | Hold → Buy |
2021-08-20 | Iniziato | Oppenheimer | Perform |
2020-11-25 | Aggiornamento | Raymond James | Mkt Perform → Strong Buy |
2020-04-08 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
2019-04-01 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
2018-04-03 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
2018-01-05 | Downgrade | Craig Hallum | Buy → Hold |
2017-04-07 | Reiterato | Cantor Fitzgerald | Overweight |
2017-03-30 | Downgrade | KeyBanc Capital Mkts | Overweight → Sector Weight |
2017-02-08 | Iniziato | Barclays | Equal Weight |
2016-11-04 | Iniziato | Cantor Fitzgerald | Buy |
2016-04-08 | Ripresa | Piper Jaffray | Neutral |
2016-01-08 | Reiterato | Canaccord Genuity | Buy |
2015-11-10 | Downgrade | Raymond James | Outperform → Mkt Perform |
2015-07-24 | Iniziato | KeyBanc Capital Mkts | Overweight |
2014-06-19 | Aggiornamento | Canaccord Genuity | Hold → Buy |
2012-10-09 | Reiterato | Canaccord Genuity | Hold |
2012-06-25 | Downgrade | Canaccord Genuity | Buy → Hold |
2011-07-15 | Aggiornamento | Canaccord Genuity | Hold → Buy |
2011-07-15 | Aggiornamento | Stifel Nicolaus | Hold → Buy |
2011-06-14 | Downgrade | Wedbush | Neutral → Underperform |
2010-09-08 | Reiterato | Wedbush | Neutral |
Mostra tutto
Angiodynamic Inc Borsa (ANGO) Ultime notizie
What hedge fund activity signals for AngioDynamics Inc. stock2025 Volatility Report & Verified Entry Point Signals - newser.com
Will AngioDynamics Inc. stock continue dividend increasesWeekly Trade Summary & Consistent Income Trade Recommendations - nchmf.gov.vn
Is AngioDynamics Inc. stock a good choice for value investors2025 Valuation Update & Precise Trade Entry Recommendations - Trung tâm Dự báo KTTV quốc gia
Ideas Watch: Will AngioDynamics Inc. stock return to pre crisis levels2025 Risk Factors & Low Drawdown Trading Strategies - nchmf.gov.vn
Why AngioDynamics Inc. (UG2) stock trades below fair valueJuly 2025 Review & Risk Controlled Stock Alerts - newser.com
Day Trade: Is AngioDynamics Inc. stock a good choice for value investorsPortfolio Risk Summary & Long-Term Growth Portfolio Plans - nchmf.gov.vn
Time magazine names Latham-based AngioDynamics' cancer-fighting NanoKnife a top invention - Times Union
Published on: 2025-10-15 06:33:40 - newser.com
Analyzing AngioDynamics Inc. with multi timeframe chartsJuly 2025 Decliners & Smart Investment Allocation Insights - newser.com
Can technical indicators confirm AngioDynamics Inc.’s reversal - newser.com
Custom watchlist performance reports with AngioDynamics Inc.July 2025 EndofMonth & Weekly Top Gainers Alerts - newser.com
AngioDynamics Inc (ANGO) CEO James Clemmer Purchases 10,000 Shar - GuruFocus
AngioDynamics Inc UG2 Stock Analysis and ForecastBreakout Stock Watch & Capital Efficiency Improvement - earlytimes.in
AngioDynamics Eyes Growth Despite Tariffs - Yahoo Finance
AngioDynamics (NASDAQ:ANGO) Shares Gap Up Following Better-Than-Expected Earnings - Defense World
AngioDynamics Raises Forecast As Med Tech Sales Outperform - Finimize
ANGIODYNAMICS INC SEC 10-Q Report - TradingView
AngioDynamics Inc (ANGO) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Raised ... - Yahoo Finance
AngioDynamics: Discounted Sales Multiple With Real Growth Engines (NASDAQ:ANGO) - Seeking Alpha
Why Did AngioDynamics Stock Pop Today? - The Motley Fool
Nasdaq Surges 100 Points; AngioDynamics Posts Upbeat Q1 Results - Benzinga
AngioDynamics Inc reports results for the quarter ended August 31Earnings Summary - TradingView
Transcript : AngioDynamics, Inc., Q1 2026 Earnings Call, Oct 02, 2025 - MarketScreener
AngioDynamics, Inc. Reports Earnings Results for the First Quarter Ended August 31, 2025 - MarketScreener
AngioDynamics Inc. Q1 Loss Decreases, Beats Estimates - Nasdaq
Stock Market Today: Dow Futures Slip, Nasdaq Rises Amid Mixed Trade—AngioDynamics, Entero Therapeutics, Fermi In FocusSPDR S&P 500 (ARCA:SPY) - Benzinga
Voya Investment Management LLC Has $103,000 Position in AngioDynamics, Inc. $ANGO - Defense World
Top Wall Street Forecasters Revamp AngioDynamics Expectations Ahead Of Q1 Earnings - Benzinga
Earnings To Watch: AngioDynamics Inc (ANGO) Reports Q1 2026 Result - Yahoo Finance
AngioDynamics Inc expected to post a loss of 12 cents a shareEarnings Preview - TradingView
What drives AngioDynamics Inc stock pricePrice Volatility Patterns & Master Technical Analysis With Free Tools - earlytimes.in
Chart based analysis of AngioDynamics Inc. trendsJuly 2025 Fed Impact & Safe Swing Trade Setup Alerts - newser.com
Why AngioDynamics Inc. (UG2) stock signals breakout potentialJuly 2025 Institutional & Stepwise Swing Trade Plans - newser.com
Is AngioDynamics Inc. (UG2) stock a safe buy pre earningsMarket Performance Summary & AI Powered Market Entry Ideas - newser.com
How buyback programs support AngioDynamics Inc. (UG2) stock2025 Momentum Check & Risk Controlled Stock Pick Alerts - newser.com
What valuation ratios show for AngioDynamics Inc. (UG2) stock2025 Top Decliners & Weekly High Potential Stock Alerts - newser.com
Assenagon Asset Management S.A. Purchases 72,826 Shares of AngioDynamics, Inc. $ANGO - MarketBeat
Rhumbline Advisers Reduces Stake in AngioDynamics, Inc. $ANGO - Defense World
Can AngioDynamics Inc. hit a new high this monthJuly 2025 Selloffs & Free Real-Time Volume Trigger Notifications - newser.com
Can a trend reversal in AngioDynamics Inc. lead to recoveryWeekly Trade Recap & AI Powered Market Entry Ideas - newser.com
Strs Ohio Buys Shares of 54,700 AngioDynamics, Inc. $ANGO - MarketBeat
Forecasting AngioDynamics Inc. price range with options dataWeekly Market Report & Community Consensus Picks - newser.com
What to do if you’re stuck in AngioDynamics Inc.Weekly Trade Analysis & Low Risk High Reward Trade Ideas - newser.com
Understanding AngioDynamics Inc.’s price movementWeekly Earnings Recap & Proven Capital Preservation Tips - newser.com
Backtesting results for AngioDynamics Inc. trading strategiesEarnings Growth Summary & Entry Point Strategy Guides - newser.com
When is the best time to exit AngioDynamics Inc.Market Movement Recap & Safe Entry Momentum Tips - newser.com
What recovery options are there for AngioDynamics Inc.Exit Point & AI Driven Price Predictions - newser.com
Angiodynamic Inc Azioni (ANGO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Angiodynamic Inc Azioni (ANGO) insider trading
Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
---|---|---|---|---|---|---|---|
Trowbridge Stephen A | EVP and CFO |
Oct 13 '25 |
Buy |
11.16 |
890 |
9,932 |
256,629 |
Clemmer James C | President and CEO |
Oct 09 '25 |
Buy |
11.15 |
10,000 |
111,500 |
882,529 |
Nighan Warren JR | SVP Quality and Regulatory |
Jan 16 '25 |
Sale |
12.31 |
4,060 |
49,979 |
41,817 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):